Page last updated: 2024-10-16

allantoin and Hematologic Neoplasms

allantoin has been researched along with Hematologic Neoplasms in 1 studies

Hematologic Neoplasms: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.

Research Excerpts

ExcerptRelevanceReference
"Allantoin was analyzed as the product of uric acid oxidation."1.31Impaired plasma antioxidative defense and increased nontransferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantation. ( Berger, HM; Dürken, M; Finckh, B; Fischer, R; Herrnring, C; Kohlschütter, A; Kohlschütter, B; Moison, RM; Nagel, S; Nielsen, P; Pichlmeier, U; Zander, AR, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dürken, M1
Herrnring, C1
Finckh, B1
Nagel, S1
Nielsen, P1
Fischer, R1
Berger, HM1
Moison, RM1
Pichlmeier, U1
Kohlschütter, B1
Zander, AR1
Kohlschütter, A1

Other Studies

1 other study available for allantoin and Hematologic Neoplasms

ArticleYear
Impaired plasma antioxidative defense and increased nontransferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantation.
    Free radical biology & medicine, 2000, Mar-15, Volume: 28, Issue:6

    Topics: Allantoin; Antineoplastic Agents; Antioxidants; Bone Marrow Transplantation; Busulfan; Combined Moda

2000